Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
OncLive Global Expo
Giants of Cancer Care
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
<< View all publications

Special Issues

The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia
The Shifting Therapeutic Spectrum for Chronic Lymphocytic Leukemia
The Changing Chronic Lymphocytic Leukemia Treatment Paradigm   >   Articles
An Investigator's Perspective on the Chronic Lymphocytic Leukemia Research Front
An Investigator's Perspective on the Chronic Lymphocytic Leukemia Research Front
The Changing Chronic Lymphocytic Leukemia Treatment Paradigm   >   Articles
New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates
New Directions in Chronic Lymphocytic Leukemia Care: A Review of 2019 Treatment Guideline Updates
The Changing Chronic Lymphocytic Leukemia Treatment Paradigm   >   Articles
Nivolumab/Ipilimumab Combo Leads to Durable Responses in Metastatic Melanoma With Asymptomatic Brain Mets
Nivolumab/Ipilimumab Combo Leads to Durable Responses in Metastatic Melanoma With Asymptomatic Brain Mets
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Second Relapse Common After Initial Melanoma Recurrence on Adjuvant PD-1 Inhibition
Second Relapse Common After Initial Melanoma Recurrence on Adjuvant PD-1 Inhibition
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Palbociclib Demonstrates Activity in Acral Lentiginous Melanoma Subtype
Palbociclib Demonstrates Activity in Acral Lentiginous Melanoma Subtype
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Continued Survival Benefits Observed With Encorafenib/Binimetinib Combo in Advanced Melanoma
Continued Survival Benefits Observed With Encorafenib/Binimetinib Combo in Advanced Melanoma
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Neoadjuvant T-VEC May Reduce Recurrence in Operable Melanoma
Neoadjuvant T-VEC May Reduce Recurrence in Operable Melanoma
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Dabrafenib/Trametinib Combo Provides Lasting Control for <em>BRAF</em> V600-Mutant Metastatic Melanoma
Dabrafenib/Trametinib Combo Provides Lasting Control for BRAF V600-Mutant Metastatic Melanoma
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
PD-1 Inhibitor Spartalizumab Plus Dabrafenib/Trametinib Active in BRAF+ Melanoma
PD-1 Inhibitor Spartalizumab Plus Dabrafenib/Trametinib Active in BRAF+ Melanoma
ASCO 2019: Therapeutic Updates in Melanoma   >   Articles
Next Page >>
Publication Bottom Border
Border Publication
 
x